MC
XENT

Menta Capital’s Intersect ENT, Inc XENT Stock Holding History

Menta Capital’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-20,876
Closed -$782K – 765
2018
Q2 		$782K Sell
20,876
-1,957
-9% -$76.8K 0.18% 209
2018
Q1 		$897K Sell
22,833
-7
-0% -$256 0.19% 205
2017
Q4 		$740K Buy
22,840
+19
+0.1% +$570 0.14% 257
2017
Q3 		$711K Sell
22,821
-43,378
-66% -$1.28M 0.1% 352
2017
Q2 		$1.85M Sell
66,199
-37,198
-36% -$842K 0.22% 144
2017
Q1 		$1.77M Sell
103,397
-13,463
-12% -$189K 0.17% 187
2016
Q4 		$1.41M Buy
116,860
+4,945
+4% +$64K 0.12% 295
2016
Q3 		$1.77M Buy
111,915
+19,374
+21% +$292K 0.17% 203
2016
Q2 		$1.2M Buy
92,541
+53,049
+134% +$830K 0.16% 185
2016
Q1 		$750K Sell
39,492
-19,296
-33% -$350K 0.1% 322
2015
Q4 		$1.32M Sell
58,788
-24,902
-30% -$492K 0.17% 175
2015
Q3 		$1.96M Buy
83,690
+47,444
+131% +$1.31M 0.31% 75
2015
Q2 		$1.04M Buy
+36,246
New +$950K 0.17% 246
2015
Q1 		– Sell
-13,280
Closed -$246K – 842
2014
Q4 		$246K Buy
+13,280
New +$239K 0.03% 574

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Menta Capital's XENT Position: Q3 2018 in Review

Menta Capital sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 20,876 shares — an estimated $782K sold.

Menta Capital first reported a position in XENT in Q4 2014 and held it in 14 quarters. The position peaked at $1.96M in Q3 2015. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Menta Capital reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Menta Capital sold 20,876 Intersect ENT, Inc shares in Q3 2018, an estimated $782K.
  • Menta Capital first reported a position in Intersect ENT, Inc in Q4 2014 and held it in 14 quarters.
  • Menta Capital's Intersect ENT, Inc position peaked at $1.96M in Q3 2015.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Menta Capital's 13F filing for Q3 2018, filed 14 Nov 2018.